Contemporary open aortic arch repair with selective cerebral perfusion in the era of endovascular aortic repair  by Iba, Yutaka et al.
Panel 2 Iba et alContemporary open aortic arch repair with selective cerebral
perfusion in the era of endovascular aortic repairYutaka Iba, MD,a Kenji Minatoya, MD, PhD,a Hitoshi Matsuda, MD, PhD,a Hiroaki Sasaki, MD, PhD,a
Hiroshi Tanaka, MD, PhD,a Junjiro Kobayashi, MD, PhD,a and Hitoshi Ogino, MD, PhDbFrom th
cular
Tokyo
Disclosu
have
Presente
sium
Receive
for pu
Address
Natio
565-8
0022-52
Copyrig
http://dx
S72Objective: With the recent advance of endovascular aortic repair, conventional open repair for aortic arch le-
sions should be reassessed. We reviewed our contemporary open arch repair with selective antegrade cerebral
perfusion by way of the axillary artery with deep or moderate hypothermia.
Methods: From 2001 to 2011, 1007 patients (median age, 72 years) underwent open arch repair with selective
cerebral perfusion through the right axillary artery and hypothermic circulatory arrest: deep (<25C) in 48% and
moderate (25-28C) in 52%. Of the 1007 patients, 73% underwent total arch replacement and 26% emergent
surgery for aneurysm rupture or acute aortic dissection.
Results: The early mortality was 4.7% for all patients. Permanent and temporary neurologic dysfunction oc-
curred in 3.5% and 6.7%, respectively. No spinal cord injury occurred, even with moderate hypothermia.
The independent predictors of in-hospital mortality included chronic obstructive pulmonary disease, liver dys-
function, chronic kidney disease, and concomitant coronary artery bypass. The independent predictors of per-
manent neurologic dysfunction included cerebrovascular disease, emergency surgery, and concomitant
coronary artery bypass. The cumulative survival rate was 80.4% and 71.2% at 5 and 8 years, respectively. Free-
dom from reoperation related to the initial arch repair was 98.0% and 96.9% at 5 and 8 years, respectively.
Conclusions: Conventional open arch repair yielded satisfactory outcomes and should remain the standard ther-
apy, with good long-term durability in all but high-risk patients. (J Thorac Cardiovasc Surg 2013;145:S72-7)Open surgical repair for aortic arch aneurysm is associated
with considerable mortality and morbidity, especially
stroke. However, its outcome has been dramatically im-
proved by innovations in surgical technique, including brain
protection, in the past 2 decades. In particular, the wide-
spread use of antegrade selective cerebral perfusion (SCP)
for cerebral protection has contributed to the reduction in
mortality and stroke rate.1-4 However, thoracic
endovascular aortic repair (TEVAR) has been recognized
as an alternative therapeutic option for thoracic aortic
aneurysm, and it has been attempted, mainly for high-risk
patients. Although this new technology was initially applied
for descending aortic aneurysm, its adoption has extended
to complex aortic arch lesions, predominantly in conjunc-
tion with several debranching techniques of the arch vessels
as a less-invasive alternative: hybrid TEVAR.5,6 Thus,
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The Journal of Thoracic and Cardiovascular Surga benchmark for consideration of the optimal therapeutic
strategy for aortic arch aneurysm. In the present study, the
results with our well-established contemporary open arch
repair procedure during the past decade—with sophisti-
cated SCP by way of right axillary artery (RAxA) perfusion
and hypothermic circulatory arrest (HCA)—were reviewed.PATIENTS AND METHODS
From April 2001 to September 2011, 1007 consecutive patients under-
went open aortic arch repair at the National Cerebral and Cardiovascular
Center, Japan. The inclusion criteria included an approach through a me-
dian sternotomy, the use of SCP with HCA, and hemi- or partial or total
prosthetic replacement of the aortic arch. The patient characteristics are
listed in Table 1. The median age was 72 years, and 66.3% of patients
were men. The present cohort included 30 patients (3.0%) who had a con-
nective tissue disorder such as theMarfan or Loeys-Dietz syndrome. Of the
1007 patients, 33 (3.3%) had a history of previous cardiac surgery and 38
(3.8%) had undergone previous aortic surgery of the aortic root, ascending
aorta, or aortic arch. Aortic pathologic features included acute type A aortic
dissection in 230 patients (22.8%). Emergency operations were performed
in 259 patients (25.7%), including 76 (7.5%) with shock.
The surgical variables are listed in Table 2. In most patients (73.1%),
total arch replacement (TAR) was performed. Concomitantly, coronary ar-
tery bypass grafting (CABG) was performed in 186 patients (18.5%) and
root replacement in 59 (5.9%).
Data were collected from the medical records for the patients who were
followed up in our outpatient department. The data for the others were in-
vestigated by telephone or mail. The follow-up rate was 93.0%. The mean
follow-up period was 44.9 33.7 months, with a maximum of 128 months.
The institutional review board of our center approved the present retrospec-
tive study and waived patient consent on the condition that the patients
were not identified.ery c March 2013
Iba et al Panel 2Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CKD ¼ chronic kidney disease
COPD ¼ chronic obstructive pulmonary
disease
CVD ¼ cerebrovascular disease
HCA ¼ hypothermic circulatory arrest
PND ¼ permanent neurologic dysfunction
RAxA ¼ right axillary artery
SCP ¼ selective cerebral perfusion
TAR ¼ total arch replacement
TEVAR ¼ thoracic endovascular aortic repairOperative Techniques
The details of our surgical technique of open arch repair have been pre-
viously reported.7-10 Aortic arch aneurysms were approached through
a median sternotomy. For establishment of cardiopulmonary bypass,
perfusion by way of the distal part of the RAxA in the axilla was
routinely used, in conjunction with ascending aortic or femoral artery
cannulation. Our routine brain protection was SCP, with perfusion
through the RAxA and 2 other arch vessels, with deep or moderate
HCA. In the early series, the lowest bladder and nasopharyngeal
temperatures during HCA were 16 to 22C. With the increase in our
experience, both temperatures were increased gradually to 28C, except
for high-risk patients with cerebrovascular disease (CVD) or chronic kid-
ney disease (CKD). Thus, for 529 patients (52.5%), moderate HCA of
25 to 28C was applied. After the introduction of HCA, RAxA perfusion
enabled quick conversion to SCP by clamping the innominate artery. After
the ascending aorta and aortic arch were opened, balloon-tipped SCP can-
nulas were inserted into the left carotid and left subclavian arteries.
Open distal anastomosis was performed during HCA of the lower body.
In TAR, a stepwise distal anastomosis was frequently used for an easy and
secure anastomosis. An invaginated tube graft was inserted into the de-
scending aorta. The proximal end was anastomosed to the descending
aorta, and the distal end of the inserted graft was extracted proximally. De-
bris was flushed from the descending aorta by femoral artery perfusion. The
multibranched arch graft was connected to this interposed graft. Then, the
systemic circulation was resumed through a side branch of the arch graft.
The left subclavian artery was reconstructed using a branch of the main
graft, and the patient was rewarmed to 30 to 32C. The proximal aortic
anastomosis was made above the sinotubular junction. Finally, the coro-
nary circulation was initiated by unclamping the main graft. The other 2
arch vessels were reconstructed with branch grafts, and the patient was
fully rewarmed.
Definitions
Early mortality was defined as death during the hospitalization or within
30 days postoperatively. Permanent neurologic dysfunction (PND) was de-
fined as the presence of either new focal or global permanent neurologic
dysfunction persisting at discharge. Transient neurologic dysfunction
was defined as the presence of postoperative reversible motor deficit, con-
fusion, agitation, or transient delirium, with normal computed tomography
findings of the brain and resolution of all symptoms before discharge. CVD
included a history of cerebrovascular event or a severe carotid artery lesion
with more than 75% stenosis or multiple plaques on the ultrasound exam-
ination. Chronic obstructive pulmonary disease (COPD) was defined asThe Journal of Thoracic and Cara forced expiratory volume less than 70% of the normal value or daily
use of a bronchodilator. Liver dysfunction was defined as a serum transam-
inase level more than twice the normal value or a total bilirubin level
greater than 2.0 mg/dL. CKD was defined as a serum creatinine level
greater than 1.5 mg/dL or a requirement for hemodialysis.
Statistical Analysis
Continuous data are presented as the mean  standard deviation. Mul-
tivariate stepwise logistic analysis was used to identify independent predic-
tors for early mortality and PND. The predictive factors with P  .1 on
univariate analysis were used for subsequent multivariate analysis. The re-
sults are presented as the odds ratios and 95% confidence intervals. Cumu-
lative survival and freedom from reoperation rates were calculated using
the Kaplan-Meier methods. All statistical analyses were performed using
SPSS software (IBM SPSS Inc, Chicago, Ill).
RESULTS
The overall early mortality, including 30-day and
in-hospital deaths, was 4.7%. It was 5.0% even for the
emergency cases. The cause of early death was low output
syndrome in 16 patients (34.0%), sepsis in 15 patients
(31.9%), respiratory failure in 10 patients (21.3%), rupture
of residual aneurysm in 3 patients (6.4%), and intestinal is-
chemia in 3 patients (6.4%). On multivariate analysis, the
independent risk factors for early mortality were COPD
(P ¼ .041), liver dysfunction (P ¼ .014), CKD
(P<.001), and concomitant CABG (P<.001; Table 3).
Cerebral deficits developed in 102 patients (10.2%) post-
operatively, including PND in 35 patients (3.5%) and tran-
sient neurologic dysfunction in 67 (6.7%). No spinal cord
injury occurred in any patient. The multivariate analysis
showed that the independent predictors for PND were
CVD (P ¼ .002), emergency surgery (P<.001), and con-
comitant CABG (P ¼ .006; Table 4).
Prolonged ventilation—for more than 72 hours—was re-
quired for 146 patients (14.5%). The length of stay in the
intensive care unit and duration of postoperative hospitali-
zation was 3 days (interquartile range, 2-6 days) and 25
days (interquartile range, 19-35 days), respectively.
During the follow-up period, there were 140 late deaths
(14.6%). Of these, 13 were aorta-related deaths, including
rupture of a descending thoracic aneurysm in 5, an abdominal
aortic aneurysm in 5, and sudden death in 3.Of the 10 patients
with aneurysm rupture, regular examinations at the hospital
had been suspended for 5, and the remaining 5 patients had
been observed medically because of their condition or
their wish. Cardiac-related deaths occurred in 25 patients
(17.9%), including congestive heart failure in 14, acutemyo-
cardial infarction in 8, and arrhythmia in 3. Other nonaortic-
or noncardiac-related deaths occurred as follows: respiratory
failure in 28patients (20.0%), cancer in 21 (15.0%), cerebro-
vascular accident in 16 (11.4%), sepsis in 10 (7.1%),
gastrointestinal complications in 5 (3.6%), renal failure in
4 (2.9%), accidents in 4 (2.9%), senility in 7 (5.0%), and
unknown in 7 (5.0%). The cumulative survival was 80.4%
and 71.2% at 5 and 8 years, respectively (Figure 1).diovascular Surgery c Volume 145, Number 3S S73
TABLE 1. Patient characteristics (n ¼ 1007)
Characteristic Value
Age (y)
Median 72
Range 12-93
Male gender 668 (66.3%)
Hypertension 828 (82.2%)
Diabetes 149 (14.8%)
Hyperlipidemia 381 (37.8%)
Smoking 221 (21.9%)
Cerebrovascular disease 124 (12.3%)
Coronary artery disease 280 (27.8%)
Ejection fraction<30% 14 (1.4%)
COPD 116 (11.5%)
Liver dysfunction 16 (1.6%)
CKD (creatinine  1.5 mg/dL) 104 (10.3%)
Patients with CKD requiring hemodialysis 16
Connective tissue disorder 30 (3.0%)
Marfan syndrome 25
Loeys-Dietz syndrome 5
Aortitis 23 (2.3%)
Previous cardiac surgery 33 (3.3%)
Aortic redo surgery 38 (3.8%)
Shock 76 (7.5%)
Emergency 259 (25.7%)
Acute dissection 230 (22.8%)
COPD, Chronic obstructive pulmonary disease; CKD, chronic kidney disease.
TABLE 2. Surgical procedures
Variable Value
Extent of graft replacement
Total arch replacement 736 (73.1%)
Partial arch replacement 28 (2.8%)
Hemiarch replacement 243 (24.1%)
Concomitant procedure
CABG 186 (18.5%)
Root replacement 59 (5.9%)
Composite graft 47
Aortic valve sparing 12
Aortic valve replacement 85 (8.4%)
Aortic valve repair 2 (0.2%)
Sinotubular junction plication 63 (6.3%)
Mitral valve replacement 5 (0.5%)
Mitral valve repair 10 (1.0%)
Tricuspid annuloplasty 9 (0.9%)
Maze 6 (0.6%)
Intraoperative variables
Lower body circulatory arrest time (min) 55.5  17.6
Selective cerebral perfusion time (min) 129.4  67.0
Myocardial ischemic time (min) 139.3  53.9
Cardiopulmonary bypass time (min) 240.3  99.2
Core temperature at HCA
Moderate (25-28C) 529 (52.5%)
Deep (<25C) 478 (47.5%)
CABG, Coronary artery bypass grafting; HCA, hypothermic circulatory arrest.
TABLE 3. Risk factors for in-hospital mortality
Factor
Univariate
P value
Multivariate
P value OR 95% CI
Previous cardiac surgery .063 .234
Panel 2 Iba et alLate aortic operations related to the previously repaired
arch segment were required for false aneurysm of the anas-
tomotic site in 12 patients and for graft infection in 2. Of the
patients with false aneurysms at the distal anastomotic site,
8 underwent TEVAR. Four patients who developed false an-
eurysms at the proximal anastomotic site and two who de-
veloped graft infection underwent redo graft replacement
of the aortic arch. Freedom from reoperation for the initially
repaired arch segment was 98.0% and 96.9% at 5 and 8
years, respectively (Figure 2, A). Other late aortic reopera-
tions unrelated to the initial aortic arch replacement in-
cluded composite graft replacement in 6, valve-sparing
root replacement in 2, completion arch replacement after
hemiarch repair in 5, descending aortic replacement in 36,
thoracoabdominal aortic replacement in 28, abdominal aor-
tic repair in 59, and endovascular repair of the descending
aorta in 46 and the abdominal aorta in 10 patients. Freedom
from all late aortic reoperations at 5 and 8 years was 78.0%
and 71.7%, respectively (Figure 2, B).CAD <.001 .223
COPD .009 .041 2.157 1.030-4.518
Liver dysfunction .007 .014 5.629 1.419-22.331
CKD (creatinine>1.5 mg/dL) <.001 <.001 4.637 2.392-8.988
Concomitant CABG <.001 <.001 3.424 1.837-6.382
Deep hypothermia (<25C) .089 .476
OR, Odds ratio; CI, confidence interval; CAD, coronary artery disease; COPD,
chronic obstructive pulmonary disease; CKD, chronic kidney disease; CABG, coro-
nary artery bypass grafting.DISCUSSION
Open aortic arch repair remains challenging, with some
difficulties. In most patients, the etiology of the arch aneu-
rysm is atherosclerosis; therefore, most of patients are quite
elderly and have many atherosclerotic lesions. However, re-
cent advances in brain protection, surgical techniques, anes-
thesia, and critical care have improved the surgicalS74 The Journal of Thoracic and Cardiovascular Surgoutcomes. Thus, antegrade SCP with HCA has achieved
widespread acceptance as a reliable brain protection tech-
nique.1-4 Recent reports have suggested some refinement
of surgical techniques, in addition to SCP, and have
demonstrated lower mortality rates of 4% to 8%.4,11-15 A
gradual increase of the core temperature during HCA
from deep to moderate hypothermia has been encouraged
to avoid deep hypothermia-associated coagulopathy and re-
duce the inflammatory substances associated with pro-
longed cardiopulmonary bypass.4,16 Our current basic
management of the core temperature during HCA with
SCP is moderate hypothermia, which has produced
favorable outcomes in aortic arch surgery.17 However,ery c March 2013
TABLE 4. Risk factors for permanent neurologic dysfunction
Factor
Univariate
P value
Multivariate
P value OR 95% CI
Elderly (age  75 y) .073 .068
CVD <.001 .002 3.374 1.589-7.162
CKD (creatinine>1.5 mg/dL) .081 .201
Emergent surgery .002 <.001 4.013 1.887-8.535
Concomitant CABG .044 .006 3.119 1.379-7.057
OR,Odds ratio; CI, confidence interval; CVD, cerebrovascular disease; CKD, chronic
kidney disease; CABG, coronary artery bypass grafting.
Iba et al Panel 2deep hypothermia of about 22C, which has a great advan-
tage for more secure brain, spinal cord, and visceral organ
protection during HCA, is still used in selected higher risk
patients with severe CVD and CKD or requiring a longer
duration of HCA of the lower body because of anticipated
difficulty in performing the distal anastomosis to the de-
scending aorta.10
To the best of our knowledge, the present study is the
largest scale study of open aortic arch replacement. The pe-
riod of surgery was limited to 10 years, and a similar surgi-
cal technique—including SCP with RAxA perfusion—was
used for all cases. Thus, we believe the outcome is worthy
of assessment. The mortality rate of 4.7% is comparable
to those of recent other reports,4,11-15 with a range of 4%
to 9%, although more than 70% of our patients
underwent more extensive TAR and 25% were
emergency cases. In addition, 15.5% of the patients were
older than 80 years, and 24.4% required concomitant
coronary or aortic root surgery. At least 10 surgeons—
including some residents—were involved in the present
series of arch repairs. In terms of the incidence of
neurologic deficits, although the overall rate of 10.2%
was similar, the stroke (PND) rate of 3.3% was lower
than those of other reports (4%-7%). We believe ourFIGURE 1. Survival curve for all patients by Kaplan-Meier method. Cu-
mulative survival rate was 80.4% and 71.2% at 5 and 8 years, respectively.
The Journal of Thoracic and Caroutcomes have been so satisfactory that our contemporary
aortic arch replacement technique should be recognized as
the standard repair for arch aneurysms.
With regard to risk factor analyses, the independent risk
factors for early mortality were COPD, liver dysfunction,
CKD, and concomitant CABG. The number of in-hospital
deaths from respiratory failure, in particular, interstitial
pneumonia or pulmonary fibrosis, has recently increased
with the increase in patient age. These serious complica-
tions seem to be untreatable after their occurrence postoper-
atively. For these patients, arch TEVAR should be
recommended. Regarding CKD and concomitant CABG,
most such patients have more severe atherosclerosis and
are critically compromised hosts, with diabetes and hemo-
dialysis. For some of these patients, percutaneous coronary
intervention before arch repair might be a good option to
improve the outcome.
In terms of PND, CVD, emergency operation, and con-
comitant CABG were risk factors. The former 2 factors
are easily recognized as risk factors for stroke. More me-
ticulous brain protection with deep hypothermia is recom-
mended for such conditions. A requirement for
concomitant CABG is another risk factor for stroke. We
believe this did not result from technical problems, but
rather that these patients tended to have severe atheroscle-
rotic vascular lesions, particularly in the aorta, arch ves-
sels, or intracranial arteries, which might be related to
the occurrence of stroke.
Regarding the technical aspect, our aortic arch repair
technique has some characteristic features. The first is our
routine use of RAxA perfusion by simple direct cannulation
in the axilla.7 It can be established easily and quickly, even
in an emergency setting, and can prevent the cerebral em-
boli caused by retrograde femoral artery perfusion. Right-
sided SCP through the RAxA can also be quickly achieved
by simple clamping of the innominate artery. The second
characteristic strategy is a preference for the use of stepwise
distal anastomosis with a mini- or standard elephant trunk
insertion for easier and more secure anastomoses for
TAR.8 The third technique is separate reconstruction of
the arch vessels using a multibranched prosthetic graft for
TAR.2 We are encouraged to thoroughly remove the ather-
omatous arterial wall around the origin of the arch vessels
and to perform the anastomosis at less atherosclerotic parts
of the arch vessels, resulting in fewer embolic cerebrovas-
cular events.
Long-term survival after open aortic arch repair has been
demonstrated in some other reports. Kazui and colleagues2
reported an actuarial survival at 5 and 7 years of 79% and
77%, respectively, and a recent report by Patel and col-
leagues12 demonstrated a 12-year survival of 51.2%. Their
survival curves were similar to ours, with 80.4% and 71.7%
survival at 5 and 8 years, respectively. The median patient
age in the present series was 72 years, and some of ourdiovascular Surgery c Volume 145, Number 3S S75
FIGURE 2. A, Kaplan-Meier analysis of freedom from reoperation related to initial arch repair. The rate of freedom from reoperation for the initially re-
paired arch segment was 98.0% and 96.9% at 5 and 8 years, respectively. B, Kaplan-Meier analysis of freedom from all aortic reoperation, including other
segments. Freedom from late aortic surgery was 78.0% and 71.7% at 5 and 8 years, respectively.
Panel 2 Iba et alpatients died of cancer. Thus, we believe the long-term sur-
vival rate was acceptable in our patient cohort.
Furthermore, reoperation related to the initial arch repair
during follow-up—for anastomotic false aneurysm or graft
infection—was very rare. Most secondary aortic interven-
tions after open arch repair were necessary for the other aor-
tic lesions, including the aortic root, descending aorta, or
abdominal aorta. For anastomotic false aneurysm, open re-
pair or TEVAR can be successfully performed. In particular,
TEVAR is easily applied to such limited lesions, with the
proximal landing zone in the arch graft.
However, endovascular treatments have expanded in the
past decade, and in 2008 some commercially available de-
vices for TEVAR were introduced in Japan. Since then,
our surgical strategy for aortic arch aneurysm has gradually
shifted toward TEVAR. Currently, open aortic repair re-
mains our basic surgical option, because it has been well es-
tablished and has provided satisfactory early and long-term
outcome. However, for its lesser invasiveness, this new sur-
gical technique—including hybrid TEVAR—has been ap-
plied predominantly in limited high-risk patients,
including the elderly (>75 years old), patients with severe
comorbidities (eg, impaired cardiac, pulmonary, liver, or re-
nal function), and those with a history of previous cardiac
surgery.18 Some reports of hybrid arch procedures have
demonstrated an overall mortality rate of 3.2% to 11%
and a stroke rate of 0% to 11%.5,6,19,20 A recent meta-
analysis of 463 patients who underwent hybrid arch surgery
reported a 30-day mortality of 8.3% and an incidence of
stroke and paraplegia of 4.4% and 3.9%, respectively.21 Al-
though the study included high-risk patients unsuitable for
conventional open aortic repair, the mortality was slightly
greater rather than the current results of open arch surgery,
including in our study. In addition, the meta-analysis had
a mean follow-up period of 18.9 to 61 months, leaving the
long-term results still unclear.
Several innovations in endovascular devices and tech-
niques have occurred within the past few years. ForS76 The Journal of Thoracic and Cardiovascular Surginstance, the chimney graft technique, involving the
supra-aortic branches, which can treat up to zone 0 lesions
without sternotomy, was recently introduced. Gehringhoff
and colleagues22 reported their experience using this tech-
nique for aortic arch pathologic features in 9 patients. In
that report, 1 patient (11.1%) underwent surgical arch re-
placement because of a persistent type I endoleak, and 1
early death (11.1%) occurred. However, the safety and du-
rability of these new techniques remains unclear, and future
studies are necessary.
Comparing the outcomes between open aortic repair
and TEVAR is complicated by the patient selection bias.
In general, arch TEVAR has been indicated for higher
risk patients with severe comorbidities. Milewski and col-
leagues19 reported that hybrid arch procedures have their
primary benefit in high-risk cases, especially elderly pa-
tients previously considered at prohibitively high risk to
undergo conventional open arch repair. In the present anal-
ysis, the risk factors for early mortality were COPD, liver
dysfunction, and CKD. We agree that arch TEVAR is
a beneficial therapeutic option for patients expected to ex-
perience high mortality and morbidity with conventional
open arch repair. However, we are skeptical about the
adoption of this new technology for patients with a reason-
able operative risk and younger patients, especially those
with connective tissue disorders, because the mid- and
long-term outcomes of TEVAR are still unclear. We
have experienced extremely difficult and high-risk surgical
conversion after TEVAR required for endoleak, infection,
and esophageal fistula in some patients. These less-
invasive TEVAR repairs, including hybrid procedures,
should still be applied predominantly in high-risk patients
with advanced age or many comorbidities.
The present study had some limitations. It was a retro-
spective study of a single group of patients who underwent
open aortic arch repair with SCP. To compare the results of
the 2 surgical strategies more clearly, a multicenter, pro-
spective, randomized study is required.ery c March 2013
Iba et al Panel 2CONCLUSIONS
Awell-established contemporary open aortic arch repair
using SCP with hypothermia produced satisfactory early
and long-term outcomes and remains a standard therapy
with good long-term durability. It is highly recommended,
except for high-risk patients.References
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